Literature DB >> 26194680

Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.

Elizabeth H Baldini1, Ross A Abrams2, Walter Bosch3, David Roberge4, Rick L M Haas5, Charles N Catton6, Daniel J Indelicato7, Jeffrey R Olsen3, Curtiland Deville8, Yen-Lin Chen9, Steven E Finkelstein10, Thomas F DeLaney9, Dian Wang2.   

Abstract

PURPOSE: The purpose of this study was to evaluate the variability in target volume and organ at risk (OAR) contour delineation for retroperitoneal sarcoma (RPS) among 12 sarcoma radiation oncologists. METHODS AND MATERIALS: Radiation planning computed tomography (CT) scans for 2 cases of RPS were distributed among 12 sarcoma radiation oncologists with instructions for contouring gross tumor volume (GTV), clinical target volume (CTV), high-risk CTV (HR CTV: area judged to be at high risk of resulting in positive margins after resection), and OARs: bowel bag, small bowel, colon, stomach, and duodenum. Analysis of contour agreement was performed using the simultaneous truth and performance level estimation (STAPLE) algorithm and kappa statistics.
RESULTS: Ten radiation oncologists contoured both RPS cases, 1 contoured only RPS1, and 1 contoured only RPS2 such that each case was contoured by 11 radiation oncologists. The first case (RPS 1) was a patient with a de-differentiated (DD) liposarcoma (LPS) with a predominant well-differentiated (WD) component, and the second case (RPS 2) was a patient with DD LPS made up almost entirely of a DD component. Contouring agreement for GTV and CTV contours was high. However, the agreement for HR CTVs was only moderate. For OARs, agreement for stomach, bowel bag, small bowel, and colon was high, but agreement for duodenum (distorted by tumor in one of these cases) was fair to moderate.
CONCLUSIONS: For preoperative treatment of RPS, sarcoma radiation oncologists contoured GTV, CTV, and most OARs with a high level of agreement. HR CTV contours were more variable. Further clarification of this volume with the help of sarcoma surgical oncologists is necessary to reach consensus. More attention to delineation of the duodenum is also needed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26194680      PMCID: PMC4684186          DOI: 10.1016/j.ijrobp.2015.04.039

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  29 in total

1.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

Review 2.  Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel.

Authors:  Elizabeth H Baldini; Dian Wang; Rick L M Haas; Charles N Catton; Daniel J Indelicato; David G Kirsch; David Roberge; Kilian Salerno; Curtiland Deville; B Ashleigh Guadagnolo; Brian O'Sullivan; Ivy A Petersen; Cecile Le Pechoux; Ross A Abrams; Thomas F DeLaney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-01       Impact factor: 7.038

3.  Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation.

Authors:  Sean M McBride; Chandrajit P Raut; Michelle Lapidus; Phillip M Devlin; Karen J Marcus; Monica Bertagnolli; Suzanne George; Elizabeth H Baldini
Journal:  Ann Surg Oncol       Date:  2013-02-08       Impact factor: 5.344

4.  Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer.

Authors:  Jonathan Verma; Erik P Sulman; Anuja Jhingran; Susan L Tucker; Gaiane M Rauch; Patricia J Eifel; Ann H Klopp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

5.  Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.

Authors:  E Stoeckle; J M Coindre; S Bonvalot; G Kantor; P Terrier; F Bonichon; B Nguyen Bui
Journal:  Cancer       Date:  2001-07-15       Impact factor: 6.860

6.  Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.

Authors:  A Gronchi; R Miceli; C Colombo; S Stacchiotti; P Collini; L Mariani; C Sangalli; S Radaelli; R Sanfilippo; M Fiore; P G Casali
Journal:  Ann Oncol       Date:  2011-07-16       Impact factor: 32.976

7.  Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.

Authors:  Elizabeth H Baldini; Walter Bosch; John M Kane; Ross A Abrams; Kilian E Salerno; Curtiland Deville; Chandrajit P Raut; Ivy A Petersen; Yen-Lin Chen; John T Mullen; Keith W Millikan; Giorgos Karakousis; Michael L Kendrick; Thomas F DeLaney; Dian Wang
Journal:  Ann Surg Oncol       Date:  2015-05-28       Impact factor: 5.344

8.  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.

Authors:  Brian O'Sullivan; Aileen M Davis; Robert Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Rita Kandel; Karen Goddard; Anna Sadura; Joseph Pater; Benny Zee
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

9.  Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.

Authors:  Alessandro Gronchi; Salvatore Lo Vullo; Marco Fiore; Chiara Mussi; Silvia Stacchiotti; Paola Collini; Laura Lozza; Elisabetta Pennacchioli; Luigi Mariani; Paolo Giovanni Casali
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

10.  Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity.

Authors:  Houda Bahig; David Roberge; Walter Bosch; William Levin; Ivy Petersen; Michael Haddock; Carolyn Freeman; Thomas F Delaney; Ross A Abrams; Danny J Indelicato; Elizabeth H Baldini; Ying Hitchcock; David G Kirsch; Kevin R Kozak; Aaron Wolfson; Dian Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-03-06       Impact factor: 7.038

View more
  10 in total

Review 1.  [Pre- or postoperative radiotherapy essential for the treatment of retroperitoneal sarcomas].

Authors:  Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2016-11       Impact factor: 3.621

2.  Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.

Authors:  Elizabeth H Baldini; Walter Bosch; John M Kane; Ross A Abrams; Kilian E Salerno; Curtiland Deville; Chandrajit P Raut; Ivy A Petersen; Yen-Lin Chen; John T Mullen; Keith W Millikan; Giorgos Karakousis; Michael L Kendrick; Thomas F DeLaney; Dian Wang
Journal:  Ann Surg Oncol       Date:  2015-05-28       Impact factor: 5.344

Review 3.  Advances in Radiation Therapy for Primary and Metastatic Adult Soft Tissue Sarcomas.

Authors:  Philip Blumenfeld; Neilayan Sen; Ross Abrams; Dian Wang
Journal:  Curr Oncol Rep       Date:  2016-06       Impact factor: 5.075

4.  Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy.

Authors:  Simon Kirste; Nicole Landenberger; Jutta Scholber; Karl Henne; Uwe A Wittel; Anca-Ligia Grosu
Journal:  Strahlenther Onkol       Date:  2019-04-10       Impact factor: 3.621

5.  Convolutional neural network-based automatic liver delineation on contrast-enhanced and non-contrast-enhanced CT images for radiotherapy planning.

Authors:  Naohiro Sakashita; Kiyonori Shirai; Yoshihiro Ueda; Ayuka Ono; Teruki Teshima
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-02

6.  MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma.

Authors:  Matthew B Spraker; Landon S Wootton; Daniel S Hippe; Kevin C Ball; Jan C Peeken; Meghan W Macomber; Tobias R Chapman; Michael N Hoff; Edward Y Kim; Seth M Pollack; Stephanie E Combs; Matthew J Nyflot
Journal:  Adv Radiat Oncol       Date:  2019-02-23

7.  Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.

Authors:  Pippa F Cosper; Jeffrey Olsen; Todd DeWees; Brian A Van Tine; William Hawkins; Jeff Michalski; Imran Zoberi
Journal:  Radiat Oncol       Date:  2017-12-08       Impact factor: 3.481

8.  Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.

Authors:  Rick L M Haas; Sylvie Bonvalot; Rosalba Miceli; Dirk C Strauss; Carol J Swallow; Peter Hohenberger; Frits van Coevorden; Piotr Rutkowski; Dario Callegaro; Andrew J Hayes; Charles Honoré; Mark Fairweather; Rebecca Gladdy; Jens Jakob; Milena Szacht; Marco Fiore; Peter W Chung; Winan J van Houdt; Chandrajit P Raut; Alessandro Gronchi
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

Review 9.  Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents.

Authors:  Cameron M Callaghan; M M Hasibuzzaman; Samuel N Rodman; Jessica E Goetz; Kranti A Mapuskar; Michael S Petronek; Emily J Steinbach; Benjamin J Miller; Casey F Pulliam; Mitchell C Coleman; Varun V Monga; Mohammed M Milhem; Douglas R Spitz; Bryan G Allen
Journal:  Cancers (Basel)       Date:  2020-08-12       Impact factor: 6.639

10.  Does magnetic resonance imaging improve soft tissue sarcoma contouring for radiotherapy?

Authors:  Alexander John Vickers; Niluja Thiruthaneeswaran; Catherine Coyle; Prakash Manoharan; James Wylie; Lucy Kershaw; Ananya Choudhury; Alan Mcwilliam
Journal:  BJR Open       Date:  2019-05-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.